Edition:
United States

Sunesis Pharmaceuticals Inc (SNSS.OQ)

SNSS.OQ on NASDAQ Stock Exchange Capital Market

4.18USD
2:55pm EDT
Change (% chg)

$0.07 (+1.70%)
Prev Close
$4.11
Open
$4.11
Day's High
$4.25
Day's Low
$4.11
Volume
23,718
Avg. Vol
11,141
52-wk High
$6.24
52-wk Low
$2.70

SNSS.OQ

Chart for SNSS.OQ

About

Sunesis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The Company offers QINPREZO (vosaroxin), which is a product candidate for the treatment of acute myeloid leukemia... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $86.00
Shares Outstanding(Mil.): 20.92
Dividend: --
Yield (%): --

Financials

  SNSS.OQ Industry Sector
P/E (TTM): -- 47.98 29.94
EPS (TTM): -2.48 -- --
ROI: -126.12 -2.56 13.01
ROE: -578.30 5.14 14.16

BRIEF-Sunesis Pharmaceuticals provides update on EU marketing app for vosaroxin

* Sunesis pharmaceuticals announces submission of responses to ema day 180 list of outstanding issues for marketing authorization application for vosaroxin

Mar 22 2017

BRIEF-Sunesis Pharma announces clinical and regulatory updates to SNS-062 and vosaroxin programs

* Sunesis pharmaceuticals announces clinical and regulatory updates to SNS-062 and vosaroxin programs

Jan 23 2017

BRIEF-Sunesis Pharmaceuticals qtrly rev $0.6 mln vs $0.7 mln

* Sunesis pharmaceuticals reports third quarter 2016 financial results and recent highlights

Nov 03 2016

BRIEF-Sunesis announces pricing of $25 mln offering of securities

* Sunesis announces pricing of $25 million offering of securities

Oct 19 2016

BRIEF-Sunesis announces proposed public offering of common stock and preferred stock

* Sunesis announces proposed public offering of common stock and preferred stock

Oct 18 2016

BRIEF-Sunesis announces submission of responses to the EMA Day 120 list of questions

* Sunesis announces submission of responses to the EMA Day 120 list of questions for marketing authorization application for Vosaroxin

Oct 13 2016

More From Around the Web

Competitors

  Price Chg
Eisai Co., Ltd (4523.T) ¥5,928 -114.00
Johnson & Johnson (JNJ.N) $125.83 +0.35
Novartis AG (NOVN.S) CHF73.85 +0.10
Pfizer Inc. (PFE.N) $34.14 +0.14
Merck & Co., Inc. (MRK.N) $63.26 +0.08
Celgene Corporation (CELG.OQ) $125.13 +1.75

Earnings vs. Estimates